ABSTRACT. Estradiol-producing ovarian cysts were found in four very preterm females at a postconceptional age that slightly preceded the expected time of delivery. The serum concentration of estradiol was very high. In the first infant one cystic ovary was removed surgically. When cysts appeared in the other ovary, the girl was treated with medroxyprogesterone acetate. The serum concentration of estradiol then fell and the cysts disappeared. Medroxyprogesterone acetate treatment was given also to the second girl, who had a high and rising serum concentration of estradiol. In infants 3 and 4 the cysts disappeared and the serum estradiol normalized spontaneously. Measurements of serum concentrations of luteinizing hormone and foiliclestimulating hormone before and after an iv injection of luteinizing hormone releasing hormone showed that preterm girls with early estradiol-producing ovarian cysts have a postpubertal type of response to luteinizing hormonereleasing hormone. When the test is repeated some months later they have a prepubertal type of response, which is normal for their age. It has been demonstrated that the serum concentration of estrogens in full-term newborn infants decreases rapidly during the first hours after birth (I). A high serum level of estradiol is unlikely in newborn infants beyond the early neonatal period and few measurements have been made in early infancy. Recently high serum levels of FSH and LH have been found in preterm girls (2). Also, there have been few reports of estradiolproducing ovarian cysts in childhood; most reported cases have been associated with precocious puberty (3). As far as we know such ovarian cysts have not been reported during the neonatal period. Herein we report four cases of estradiol-producing ovarian cysts in preterm girls.
MATERIALS AND METHODS
Four preterm girls were found to have estradiol-producing ovarian cysts. All were born before the 30th wk of gestation. Symptoms, including swelling of the labia majora, appeared at a time corresponding to 1-4 wk before the expected time of delivery, ie, 34-37 wk postconceptionally, or at 36-39 completed gestational weeks. A brief description of each case is given below. Maturity was assessed in all cases from external characteristics and on the basis of neurological criteria (4, 5) . Immunoreactive FSH and LH in serum were assayed by a radioimmunosorbent technique with indirectly coupled antibodies (6). Immunoreactive estradiol in serum was measured by a radioimmunological method using an antiserum to an estradiol-6-oxime-bovine serum albumin conjugate (7). For the LHRH test informed consent was obtained from the parents. Ultrasonic examination was performed with a dynamic sector scanner (ATL Mark 300, 7.5 MHz, ATL, Seattle, WA), and included both scanning for cysts and determination of uterine size. The latter was measured as the length of the uterus and this determination required that some urine was left in the bladder when the examination was made.
Infant 1 was born after 26 wk of gestation; birth weight was 545) 852 g and birth length 34 cm. The mother was healthy during this pregnancy. In the last 2 days before delivery she was treated with terbutaline because of preterm labor. The infant was delivered vaginally with a head presentation. After birth, the infant was in good condition with Apgar scores of 8 and 9 one and 5 min after birth. Physical examination revealed no respiratory disturbances. Assessment of maturity (4, 5) indicated a gestational age of 26 completed wk. During the neonatal period, the infant was treated with theophylline and CPAP because of recurrent apnea. Oral feeding was started early. The body weight was at its lowest (675 g) 6 days after birth and then gradually increased. At 2% months of age the infant's labia majora became edematous. Edema was also observed over the lower parts of the abdomen and on the legs. An ultrasonic examination of the abdomen and pelvis revealed a multilocular cystic tumor in the Oophorectorny left s~d e pmol/L f 1 lower left part of the abdomen, with a maximal diameter of 40 mm. The uterus measured 37 x 17 x 17 mm, which was much larger than expected for her age. The serum concentration of estradiol was 5300 pmol/liter, which is 10 times higher than that in the late follicular phase of the normal menstrual cycle of ;I fertile woman. A laparotomy was performed. The left ovary was found to be plum-sized, thin-walled, and cystic. The cystic left ovary was removed. The right ovary was of normal size and contained a small cyst, measuring a few millimetres in diameter. After the oophorectomy the serum concentration of estradiol fell1 to 440 pmol/liter ( Fig. 1 ) and the edema of the labia majora subsided. One week after surgery the edema increased again and the serum concentration of estradiol 11 days after surgery was 920 pmol/liter. Ultrasonography now revealed cysts in the remaining right ovary, the largest one having a diameter of 210 mm. Histopathological examination of the excised left ovary showed multiple follicular cysts and a stroma with a possible increase in theca cells. There were no signs of malignancy. Considering that the ovary may have become cystic as a result of gonadotrophin hyperstimulation, MPA was given. Initially an oral dose of 2.5 mg daily was administered, later decreased to 1.25 mg daily. Figure 1 shows the time course of the serum concentrations of estradiol. During treatment with MPA the serum concentration of estradiol fell and remained low. Repeated ultrasonography showed a disappearance of the ovarian cysts as the serum concentration of estradiol fell (8) . Three weeks after discontinuation of MPA therapy, 100 pg of LHRH were injected iv and the serum concentrations of FSH and LH were measured before and 45 min after the injection (see "Results").
Infant 2 was born after 28 wk gestation with a birth weight of 767 g and a birth length of 35 cm. She was small for gestational age. Three weeks before delivery signs of intrauterine growth retardation were observed. When pathological cardiotocographic recordings were observed, the infant was delivered by cesarean section. After birth the infant was in good condition. Apgar scores were 7 and 9 one and 5 min after birth. The infant developed hyaline membrane disease and was treated with CPAP for 14 days, first because of the lung disease and later because of recurrent apnoea. She was also given theophylline.
At 1 1 wk of age edema was observed in the lower part of the abdominal wall and the labia majora. Ultrasonography of the abdomen revealed fluid-filled cavities diagnosed as ovarian cysts. The serum concentration of estradiol was 2000 pmol/liter. During the following week two further estradiol determinations were 2800 and 3200 pmol/liter. An LHRH test was also performed. Because of the ovarian cysts and the concurrently high and increasing serum concentrations of estradiol, treatment with MPA 5.0 mg daily was instituted. The serum concentration of estradiol decreased but the ovarian cysts persisted and the MPA dose was increased to 10 mg daily. Figure 2 illustrates the serum concentration of estradiol during the course of treatment. Three weeks after discontinuation of MPA therapy a further LHRH test was performed (see "Results").
Infant 3 was born after 28 wk gestation with a birth weight of 794 g and a length of 37 cm. She was small for gestational age. The girl was in fair condition immediately after birth with Apgar scores of 6 and 6. Because spontaneous breathing was insufficient, she was intubated and given HFPPV (9) . She was on HFPPV for 26 days and was then treated with CPAP for almost a month because of recurrent apnea. She was also given theophylline.
At a postnatal age of 1 1 wk a blood sample for determination of serum estradiol was taken because of slight swelling of the labia majora. In this infant a serum concentration of estradiol of 100 pmol/liter was found early after birth and at 1 1 wk of age increased to 2000 pmol/liter (Fig. 3) . Repeated determinations showed decreasing levels. An LHRH test was performed. Ultrasonography of the abdomen revealed ovarian cysts on the left side with a maximal diameter of 9-10 mm. Repeated assays of serum estradiol showed a gradual decrease in concentration and no MPA treatment was instituted. Ovarian cysts, especially on the left side, persisted during the following 8-9 wk. The result of the LHRH tests are presented in "Results". Infant 4 was born after 24 wk of gestation with a birth weight of 625 g and a birth length of 32 cm. She was in fair condition after birth, with Apgar scores of 6 and 8. Her spontaneous breathing was inadequate and she was given HFPPV almost immediately after birth. After 2 days she was extubated and put on nasal CPAP. Because of recurrent apnea, treatment with theophylline was instituted. She needed six further shorter periods on HFPPV before spontaneous breathing became stable. The treatment with CPAP was continued until she was 11 wk old. From the age of 6 wk she had edema and needed small intermittent doses of diuretics. Pulmonary radiography revealed low aeration at that time, but when the edema had disappared aeration was normal. The serum concentration of estradiol was 960 pmol/liter at a postnatal age of 3 wk. At a postnatal age of 15 wk a high value, 2100 pmol/liter, was found (Fig. 4) . Ultrasonography of the pelvis at that time revealed no cysts, but 2 wk later ovarian cysts were observed bilaterally. The maximum diameter was 9-10 mm. The serum concentration of estradiol fell gradually and on repeated ultrasonic examinations ovarian cysts could be seen for almost 3 months. After this period the serum concentration of estradiol had fallen to 230 pmol/liter. The result of the LHRH tests are presented in "Results".
Neither gynecomastia nor vaginal blood discharge was observed in any of these four infants. In infants 1 and 2, who had obvious local edema, the plasma concentrations of albumin were normal.
RESULTS
The serum concentrations of estradiol are presented in Figures  1-4 . In infant 1 ovarian cysts were seen for less than 2 wk after the start of MPA treatment. In infant 2, cysts were observed fclr almost 11 wk, and in infants 3 and 4 they were seen for 9 and 12 wk, respectively.
Uterine size, as determined ultrasonographically, is depicted in Figure 5 . In infant 1, who had very high serum concentratior~s of estradiol; uterine size decreased rapidly on treatment with MPA. In infant 2 there was also a very rapid decrease in uterine size after the commencement of MPA. In infant 3, in whom a spontaneous decrease in serum estradiol occurred, the uteri~lle size decreased much more slowly. In infant 4 the uterine size remained essentially unchanged during the entire study period
The results of the LHRH tests in the four infants are presented in Figure 6 . In infant 1 only one test was performed after discontinuation of MPA treatment, while in the other three infants one test was camed out at the time of diagnosis and another 2-4 months after the calculated time of delivery. As seen in Figure 6 , in the first test the increase in LH was much more marked than the increase in FSH, which is a postpubertal type of response to an injection of LHRH. In the second test the FSH response was stronger than the LH response in all infants and the preinjection serum concentration of LH was low. This is a normal prepubertal response.
All infants were in good condition when the ovarian cysts disappeared. Their growth was satisfactory and their development normal. Herein we report four very preterm infants with estradiolproducing ovarian cysts. Estradiol-producing ovarian cysts cause swelling of the labia majora and sometimes edema in the lower parts of the abdominal wall. The uterine size is concomitantly increased. We found no previous reports of estradiol-producing ovarian cysts in preterm infants born before 30 wk gestation.
Clements et al. (10) and Winter et al. (1 1) reported low levels of FSH and LH in amniotic fluid in late gestation and low levels of FSH and LH in cord sera at birth of full-term infants. Polhemus (12) observed increased follicular maturation and Bidlingmeier et al. (13) found elevated serum concentrations of estradiol in full-term infants after birth. Their observations were thus made in full-term infants, while our infants were very preterm.
From a developmental point of view our finding of extremely high levels of FSH and LH measured in very preterm girls at a postconceptional age corresponding to or slightly earlier than the calculated time of delivery, indicates marked stimulation of the concentrations of estradiol. This may be a result of the high circulating levels of FSH and LH postnatally, which cause hyperstimulation of the ovaries. The withdrawal of placental steroids at birth probably results in activation of the hypothalamicpituitary-gonadal unit. In full-term newborn infants, low levels of sex steroids inhibit the hypothalamic-pituitary-gonadal unit as a result of high sensitivity in the negative feedback system (3). The negative feedback system may be too immature in preterm girls to respond to low levels of estradiol. The finding in the present study that preterm girls have a postpubertal type of response to iv injection of LHRH when first examined but have a normal prepubertal type of response some months later, suggests that normal maturation of the hypothalamic-pituitarygonadal system takes place in utero during late gestation in the presence of high levels of estrogen. The maturation process in preterm girls in the extrauterine environment occurs without the negative feedback of the placental steroids, resulting in high levels of gonadotrophins and as a consequence a tendency to develop "the ovarian hyperstimulation syndrome."
MPA inhibits release of gonadotrophins and thus prevents hyperstimulation of the ovaries. We do not recommend this treatment as a routine procedure in all cases of estradiol-producing ovarian cysts, but at the moment we see no alternative treatment in infants with very high estrogen evels (>>2000 pmol/ liter).
